Lataa...
A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy
Proteolysis-TArgeting Chimeras (PROTACs) technology, as a strategy to chemically knock down transcription factors at the protein levels, can hijack the ubiquitin-proteasome degradation system to initiate the intracellular ubiquitin-proteasome hydrolysis process to degrade proteins. In the past, the...
Tallennettuna:
| Julkaisussa: | Transl Androl Urol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947434/ https://ncbi.nlm.nih.gov/pubmed/33718095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1357 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|